Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis

October 17, 2023 — 

The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with the biopharmaceutical company Nkarta, Inc. in developing the engineered natural killer (NK) cell therapy NKX019 as a potential treatment for people with refractory lupus nephritis who have not responded to standard treatment.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release

Recent Stories & News

News Update
Letter from LRA President & CEO Albert T. Roy
May 1, 2025
Dear Friends, Lupus Awareness Month officially starts today, and with a growing coalition of people like you passionately working together...
Story
Simple Ways to Ease Stress with Lupus: Tips from Priscilla Calvache, LCSW
Tips to Lower Stress During Stress Awareness Month and Beyond
April 15, 2025
If you have lupus and often feel stressed, you're not alone! Research shows stress is common among people dealing...
Story
Community inspiration: Ali Vanderloop
Turning Diagnosis into Drive: A Community Member’s Journey that’s Accelerating Lupus Research
April 21, 2025
Like many in the lupus community, one new member, Ali VanderLoop, is turning a difficult diagnosis into powerful action...
Stay informed about events, research developments, and ways you can help. Sign up for updates